36 results
8-K
EX-1.1
AKRO
Akero Therapeutics Inc
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances
8-K
EX-1.1
rxee 23lp2g6pyocdl7w
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm
8-K
EX-1.1
fzsk 4ajpaxy71
16 Sep 22
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
6wbgq 9kjl
16 Jun 22
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
7:14am
S-3ASR
EX-1.2
g23k61rjxg
18 May 21
Automatic shelf registration
6:01am